» Articles » PMID: 15846171

Gestational Diabetes: the Consequences of Not Treating

Overview
Publisher Elsevier
Date 2005 Apr 23
PMID 15846171
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Untreated gestational diabetes mellitus carries significant risks of perinatal morbidity at all severity levels; treatment will enhance outcome.

Study Design: A matched control of 555 gravidas, gestational diabetes mellitus diagnosed after 37 weeks, were compared with 1110 subjects treated for gestational diabetes mellitus and 1110 nondiabetic subjects matched from the same delivery year for obesity, parity, ethnicity, and gestational age at delivery. The nondiabetic subjects and those not treated for gestational diabetes mellitus were matched for prenatal visits.

Results: A composite adverse outcome was 59% for untreated, 18% for treated, and 11% for nondiabetic subjects. A 2- to 4-fold increase in metabolic complications and macrosomia/large for gestational age was found in the untreated group with no difference between nondiabetic and treated subjects. Comparison of maternal size, parity, and disease severity revealed a 2- to 3-fold higher morbidity rate for the untreated groups, compared with the other groups.

Conclusion: Untreated gestational diabetes mellitus carries significant risks for perinatal morbidity in all disease severity levels. Timely and effective treatment may substantially improve outcome.

Citing Articles

Maternal and Neonatal Efficacy and Safety Outcomes of Myo-Inositol in Women With or at High Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Ali Y, Sharara M, Mahrous M, Rezk A, Abuali A, Seoudy M Diabetes Spectr. 2025; 38(1):82-92.

PMID: 39959527 PMC: 11825409. DOI: 10.2337/ds23-0065.


Gestational Diabetes-like Fuels Impair Mitochondrial Function and Long-Chain Fatty Acid Uptake in Human Trophoblasts.

Siemers K, Joss-Moore L, Baack M Int J Mol Sci. 2024; 25(21).

PMID: 39519087 PMC: 11546831. DOI: 10.3390/ijms252111534.


Myoinositol and Metformin in the Prevention of Gestational Diabetes in High-Risk Patients: A Narrative Review.

Romeo P, DAnna R, Corrado F J Clin Med. 2024; 13(18).

PMID: 39336874 PMC: 11432226. DOI: 10.3390/jcm13185387.


Does the gestational age at which the glucose challenge test (GCT) is conducted influence the diagnosis of gestational diabetes mellitus (GDM)?.

Pardo E, Yagur Y, Gluska H, Cohen G, Kovo M, Biron-Shental T Arch Gynecol Obstet. 2024; 310(3):1593-1598.

PMID: 38987458 DOI: 10.1007/s00404-024-07612-0.


Maternal Hypertriglyceridemia in Gestational Diabetes: A New Risk Factor?.

Puga F, Borges Duarte D, Silva V, Pereira M, Garrido S, Vilaverde J Nutrients. 2024; 16(11).

PMID: 38892511 PMC: 11174571. DOI: 10.3390/nu16111577.